Limited efficacy of hydroxyurea in lowering of the JAK2 V617F allele burden

By Larsen Thomas Stauffer   Pallisgaard Niels   de Stricker Karin   Møller Michael Boe   Hasselbalch Hans Carl  

Hematology, Vol. 14, Iss. 1, 2009-02 ,pp. : 11-15

Maney Publishing

Access to resources Recommend Favorite

JAK2 haplotype 46/1 and JAK2 V617F allele burden in MPN: New evidence against the “hypermutability” hypothesis?

By  

International Journal Of Laboratory Hematology, Vol. 40, Iss. 1, 2018-02 ,pp. : e8-e10

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of JAK2V617F mutation on thrombosis and myeloid transformation in essential thrombocythemia: a multivariate analysis by Cox regression in 141 patients

By Chim C. S.   Sim J. P.   Chan C. C.   Kho B. C.   Chan J. C.   Wong L. G.   Law M.   Liang R.   Kwong Y. L.  

Hematology, Vol. 15, Iss. 4, 2010-08 ,pp. : 187-192

Maney Publishing

Access to resources Recommend Favorite

JAK2^V617F positive early stage myeloproliferative disease (essential thrombocythemia) as the cause of portal vein thrombosis in two middle-aged women: therapeutic implications in view of the literature

By Michiels J.   Commandeur S.   Hoogenboom G.   Wegman J.   Scholten L.   Rijssel R.   Raeve H.  

Annals of Hematology, Vol. 86, Iss. 11, 2007-11 ,pp. : 793-800

Springer Publishing Company

Access to resources Recommend Favorite

Primary thrombophilia in México VII: the V617F mutation of JAK2 is not a frequent cause of thrombosis

By Garcés-Eisele Javier   González-Carrillo Martha L.   Reyes-Núñez Virginia   Ruiz-Argüelles Guillermo J.  

Hematology, Vol. 13, Iss. 4, 2008-08 ,pp. : 244-246

Maney Publishing

Access to resources Recommend Favorite